Of the eight cases, detection of GM-CSF autoantibodies was performed in only two lung cancer cases (Table 1); one was a case of autoimmune PAP with subsequent development of lung cancer [7], and the other was secondary PAP associated with lung cancer [8]. Here, CSF2 is linked to lung carcinoma.